Skip to main content
Livermore
Livermore
ZHEN

Hancock Whitney Corp

SEC CIK
0000750577
Latest filing
Aug 14, 2026

CORT holding history

Corcept Therapeutics Inc in every 13F filed by Hancock Whitney Corp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CORT overviewAll 13F holders of CORTFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
21
Since Q1 2021
Holdings of CORT by Hancock Whitney Corp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−10,806−100.0%Sold outHolders
Q1 202610,806$502.7K<0.1%+3,312+44.2%AddedHolders
Q4 20257,494$260.8K<0.1%−14−0.2%ReducedHolders
Q3 20257,508$624.0K<0.1%−86−1.1%ReducedHolders
Q2 20257,594$557.4K<0.1%−9,964−56.7%ReducedHolders
Q1 202517,558$2.01M0.1%−663−3.6%ReducedHolders
Q4 202418,221$918.2K<0.1%−4,733−20.6%ReducedHolders
Q3 202422,954$1.06M<0.1%+270+1.2%AddedHolders
Q2 202422,684$737.0K<0.1%−4,813−17.5%ReducedHolders
Q1 202427,497$692.6K<0.1%+15,567+130.5%AddedHolders
Q4 202311,930$387.5K<0.1%−18−0.2%ReducedHolders
Q3 202311,948$325.5K<0.1%−432−3.5%ReducedHolders
Q2 202312,380$275.0K<0.1%−5,092−29.1%ReducedHolders
Q1 202317,472$378.0K<0.1%−2,564−12.8%ReducedHolders
Q4 202220,036$407.0K<0.1%−75−0.4%ReducedHolders
Q3 202220,111$516.0K<0.1%−467−2.3%ReducedHolders
Q2 202220,578$489.0K<0.1%−789−3.7%ReducedHolders
Q1 202221,367$481.0K<0.1%−4,366−17.0%ReducedHolders
Q4 202125,733$510.0K<0.1%−203−0.8%ReducedHolders
Q3 202125,936$510.0K<0.1%−93−0.4%ReducedHolders
Q2 202126,029$573.0K<0.1%−7,755−23.0%ReducedHolders
Q1 202133,784$803.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.